Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain. - Mohammed Alrouji; Mohammed S. Alshammari; Sharif Alhajlah; Syed Tasqeeruddin; Khuzin Dinislam; Anas Shamsi; Saleha Anwar (Frontiers Bioinform., 2025)